Commentary: Health insurance premiums dropped? Not so fast
The latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of health insurance from the same time last year. That left many people scratching their heads, since you'd be hard pressed to find anyone whose premiums dropped at all, let alone by that much. Is someone cooking the books at the
The short answer is no, but the really crazy thing—which few people understand—is the BLS isn't reporting what you pay in health insurance premiums. That's why these figures don't accurately reflects what American families have experienced over the last year. Meanwhile, a plethora of other data point to premiums increasing over the last 12 months, not falling.
It turns out that health insurance is a very difficult service to measure, in part because it is inconsistent over time. Imagine a new drug becomes available, and your health insurance now covers it. This new expansion of coverage means your health insurance is not directly comparable to what it was before, and there needs to be an adjustment for this change in quality.
Additionally, health insurance is a service distinct from medical care (like a doctor's services) and medical commodities (like prescriptions), and the price changes for medical care and medical commodities are already accounted for in the CPI.
This poses an additional challenge for the BLS in measuring the cost of health insurance, because if they simply measure gross health insurance premiums, they'd mostly be counting various costs of health care, not the service of providing the insurance.
What BLS is essentially trying to measure is the difference between what the insured pays in premiums and the value of the benefits he or she receives from the insurance. That difference is called net premiums, and BLS measures it by looking at the retained earnings of health insurance companies. This methodology is highly imperfect, and the last several years have exposed the flaws in spades.
Higher costs, partly from inflation, have decreased health insurers' retained earnings over the last year, even as insurance premiums have been rising. Additionally, temporary changes in the health insurance market that followed in the wake of the pandemic caused large and unusual changes to profit margins in the industry. As those effects subside, retained earnings have fallen precipitously.
In the October CPI report, this manifested as a 34% decline in health insurance costs over the prior 12 months, even though countless other indicators show health insurance has become more expensive during the last year – not just in terms of higher gross premiums but in terms of less value to consumers.
The BLS recently made changes to its methodology of calculating health insurance costs in the CPI, but that dealt largely with how frequently the retained earnings data are updated and smoothing out sudden changes in the statistics. They still use the retained earnings model and the problems with indirect measurement of health insurance costs remain.
The sub-index for the price of health insurance is now down to its
To be fair, the alternative methodologies for measuring cost changes to health insurance are also highly imperfect, so the BLS is left to choose the least bad alternative. For example, counting gross premiums paid by the insured would capture the cost of the insurance, but then the medical care and medical commodities paid for by health insurance would effectively be double counted in the CPI.
Regardless of which flawed methodology is used, people need to be aware of how to interpret the data published by BLS. Economic statistics can be highly valuable for research and evaluating the effects of public policy, but we'd do well to remember the three kinds of lies as described by British prime minister Benjamin Disraeli: lies, damned lies, and statistics. Take everything with a grain of salt.
____
___


Beazley Selects Decision Research Corporation for Global Enterprise Rating
BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in Germany
Advisor News
- After the midterms: Addressing your clients’ tax concerns
- Berkeley arts tax heads toward passage while public bank measure looks likely to fail
- Americans’ sense of overall prosperity still ticks upward
- Turning expanded eligibility into a better coverage plan for federal clients
- Election 2026: Which of Berkeley's 7 ballot measures will pass?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Knighthead Annuity & Life Assurance Company and Merit Life Insurance Co.
- Jackson reports record annuity sales, increases share repurchase authorization
- Why the market doesn’t need more carriers
- Equitable, Corebridge steam toward merger with strong Q3 annuity sales
- Jackson Announces New Annuity Offering for AARP Members
More Annuity NewsHealth/Employee Benefits News
- Open enrollment is now for 2027 health insurance coverage in Illinois: What to know
- Idaho insurance director details $13M school trust collapse
- Insurance program's collapse detailed at ISBA conference
- Boeing retirees ‘shocked’ by 400% jump in health insurance premiums
- MEDICAID PAYMENT TRANSPARENCY RULES: STATE REPORTING REQUIREMENTS AND LIMITATIONS
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Central States Indemnity Co. of Omaha and Its Subsidiary
- National Life Group Approves $23 Million Dividends for 2027
- Milliman’s proposed $15.5 million settlement puts life insurance underwriting data in focus
- Brighthouse Financial Announces Third Quarter 2026 Results
- Prudential earnings dip as Japan sales suspension offsets U.S. growth
More Life Insurance News